| Patents for A61P 35 - Antineoplastic agents (221,099) |
|---|
| 02/19/2004 | CA2494848A1 Urea derivatives as kinase inhibitors |
| 02/19/2004 | CA2494844A1 Methods and compositions concerning poxviruses and cancer |
| 02/19/2004 | CA2494827A1 Cannabinoid receptor ligands |
| 02/19/2004 | CA2494785A1 Dihydropyrazolopyridine compounds |
| 02/19/2004 | CA2494319A1 Use of antibodies against a tumor-associated antigen |
| 02/19/2004 | CA2494270A1 Therapeutic combinations of erb b kinase inhibitors and antineoplastic therapies |
| 02/19/2004 | CA2494259A1 Epothilone derivatives |
| 02/19/2004 | CA2494252A1 Psmcs as modifiers of the rb pathway and methods of use |
| 02/19/2004 | CA2494193A1 Novel immunogenic lipopeptides comprising t-helper and cytotoxic t lymphocyte (ctl) epitopes |
| 02/19/2004 | CA2494026A1 Phosphodiesterase 4 inhibitors |
| 02/19/2004 | CA2493908A1 Thiophene compounds |
| 02/19/2004 | CA2493725A1 Antitumoral analogs of lamellarins |
| 02/19/2004 | CA2493660A1 Process for preparing quinolin antibiotic intermediates |
| 02/19/2004 | CA2493625A1 Bicyclo-pyrazoles active as kinase inhibitors, process for their preparation and pharmaceutical compositions comprising them |
| 02/19/2004 | CA2493297A1 Methods to reprogram splice site selection in pre-messenger rnas |
| 02/19/2004 | CA2492940A1 Novel difluorinated gem compounds, preparation methods thereof and applications of same |
| 02/19/2004 | CA2487399A1 Combination of anti-muscarinic agents and non-glucocorticoid steroids |
| 02/18/2004 | EP1389619A1 Pkb-3564 substance with neovascularization inhibitory activity |
| 02/18/2004 | EP1389617A1 Heterocyclic compound and antitumor agent containing the same as active ingredient |
| 02/18/2004 | EP1389466A1 Immunopotentiators |
| 02/18/2004 | EP1389464A1 Compositions containing bacterium capable of converting lactic acid into butyric acid and method of preventing/treating hyperlactic acidemia in digestive tract and colon cancer by using the same |
| 02/18/2004 | EP1389460A1 Cxcr4-antagonistic drugs comprising nitrogen-containing compound |
| 02/18/2004 | EP1389236A2 Immunoglobulin superfamily variants expressed in mesenchymal cells and therapeutic uses thereof |
| 02/18/2004 | EP1389234A2 Cd8alpha + lymphoid dendritic cell differentiated from human hematopoietic stem cell and a method for differentiation |
| 02/18/2004 | EP1389233A1 Anti-rank ligand monoclonal antibodies useful in treatment of rank ligand mediated disorders |
| 02/18/2004 | EP1389210A1 Tricyclic dihydro-quinoline derivatives, method for preparing same and pharmaceutical compositions containing same |
| 02/18/2004 | EP1389206A2 Inhibitors of c-jun n-terminal kinases (jnk) and other protein kinases |
| 02/18/2004 | EP1389205A1 Quinazoline and quinazoline-like compounds for the treatment of integrin-mediated disorders |
| 02/18/2004 | EP1389204A1 Novel sulfonamide derivatives, intermediate thereof, its preparation methods, and pharmaceutical composition comprising the same |
| 02/18/2004 | EP1389203A2 Analogs of thalidomide as potential angiogenesis inhibitors |
| 02/18/2004 | EP1389201A1 N-oxide anthranylamide derivatives and their use as medicaments |
| 02/18/2004 | EP1389197A1 Two-step conversion of protected taxane ester to paclitaxel |
| 02/18/2004 | EP1389196A1 Three-step conversion of protected taxane ester to paclitaxel |
| 02/18/2004 | EP1389132A2 Peg-conjugates of hgt-nk4 |
| 02/18/2004 | EP1389124A1 Palliative effects of morinda citrifolia oil and juice |
| 02/18/2004 | EP1389122A2 Prevention of epithelial cancer |
| 02/18/2004 | EP1389110A2 Inhibitors of macrophage migration inhibitory factor and methods for identifying the same |
| 02/18/2004 | EP1389104A2 3-aminoalkyl-2-aryl-indole derivatives and their use as gnrh antagonists |
| 02/18/2004 | EP1389103A2 Synthesis and evaluation of novel phthalimide mimics as anti-angiogenic agents |
| 02/18/2004 | EP1389101A1 Toluene sulfonamide-containing anti-tumor composition and method of use thereof |
| 02/18/2004 | EP1237408B1 Pour-on formulations |
| 02/18/2004 | EP1233786B1 Product comprising at least a no synthase inhibiting substance associated with at least a phospholipase a2 inhibiting substance for the preparation of a medicament |
| 02/18/2004 | EP1216248B1 Triazolopyrimidine derivatives |
| 02/18/2004 | EP1216238B1 Carboxylic acids and acylsulfonamides, compositions containing such compounds and methods of treatment |
| 02/18/2004 | EP1183252B1 pharmaceutically active compounds |
| 02/18/2004 | EP1178958B1 N-cyanomethyl amides as protease inhibitors |
| 02/18/2004 | EP1178822B1 Whole cell cancer vaccine comprising co-cultured malignant and non-malignant cells |
| 02/18/2004 | EP1169301B1 A topical antiandrogen for hair loss and other hyperandrogenic conditions |
| 02/18/2004 | EP1163256B1 Hemihydrate of 16.alpha.-bromoepiandrosterone |
| 02/18/2004 | EP1133477B1 Substituted benzimidazoles and their use as parp inhibitors |
| 02/18/2004 | EP1119568B1 4,5-dihydro-isoxazole derivatives and their pharmaceutical use |
| 02/18/2004 | EP1104422B1 Phenyl xanthine derivatives |
| 02/18/2004 | EP1089755B1 Pharmaceutical preparations for use in combatting or preventing surface infections caused by microorganisms |
| 02/18/2004 | EP1076663B1 Functionalized alkyl and alkenyl side chain derivatives of glycinamides as farnesyl transferase inhibitors |
| 02/18/2004 | EP1019090B1 Polymeric derivatives of camptothecins |
| 02/18/2004 | EP0983270B1 Process for preparing 6-o-monoesters of castanospermine |
| 02/18/2004 | EP0851857B1 Inhibitors of tumor necrosis factor alpha |
| 02/18/2004 | EP0734264B1 Compositions that specifically bind to colorectal cancer cells and methods of using the same |
| 02/18/2004 | EP0731838B1 Binding structures directed against the ca55.1 antigen |
| 02/18/2004 | EP0728012B1 NOVEL GnRH ANALOGUES WITH ANTITUMOUR EFFECTS AND PHARMACEUTICAL COMPOSITIONS THEREOF |
| 02/18/2004 | CN1476479A Human protooncogene and protein encoded therein |
| 02/18/2004 | CN1476478A Human cervical cancer 2 protooncogene and protein encoded therein |
| 02/18/2004 | CN1476476A Ligand/receptor specificity exchangers that redirect antibodies to receptors on pathogen |
| 02/18/2004 | CN1476448A Aryl or heteroaryl fused imidazole compounds as anti-inflammatory and analgesic agents |
| 02/18/2004 | CN1476447A Aminothiazoles and their use as adenosine receptor antagonists |
| 02/18/2004 | CN1476444A Farnesyl protein transferase inhibitors |
| 02/18/2004 | CN1476442A Pyridine derivatives with IKB-kinase (IKK-beta) INhibiting activity |
| 02/18/2004 | CN1476439A Salts of aiso thiazole-4-carboxamide and their use as anti-hyperproliferatin agents |
| 02/18/2004 | CN1476435A Fluorinated quinolones as antimitotic and antitumor agents |
| 02/18/2004 | CN1476432A Indole and dihydroindole derivatives |
| 02/18/2004 | CN1476431A Process for preparing distamycin derivatives |
| 02/18/2004 | CN1475568A New type human death resist protein, its coded sequence and use |
| 02/18/2004 | CN1475506A Fortified fusion protein FV-LDP-AE possessing angiopoiesis inhibiting and antitumour actions |
| 02/18/2004 | CN1475505A Human composite type alpha interferon protein N terminal tag structure |
| 02/18/2004 | CN1475503A New type human bone marrow substrate cell source growth inhibiting factor, its coded sequence and use |
| 02/18/2004 | CN1475498A Preparation of antigen sensitized human dendron shaped cell and its use |
| 02/18/2004 | CN1475491A Aminoglucose diphosphate and its synthesis method and preparation of medicine for treating stomash disease using said salt |
| 02/18/2004 | CN1475488A Fluoro isoflavone containing derivative, monufacturing method and its use |
| 02/18/2004 | CN1475487A Fluoro flavon containing compound, manufacturing method and its use |
| 02/18/2004 | CN1475477A Method and intermdeiate used for manufacturing antifolic acid agent |
| 02/18/2004 | CN1475276A Mixed preparation for enhancing physical cancer cell chemical theray sensitirity |
| 02/18/2004 | CN1475275A Mannan peptide freeze dried powder ampoule for injection |
| 02/18/2004 | CN1475271A Application of cytomium fortunei effectire part and monomer in medicament for anticanner and anti arthritis |
| 02/18/2004 | CN1475270A Medicine for treating cancer |
| 02/18/2004 | CN1475251A Chinese medicinal herb preparation for treating ascites type liver cancer |
| 02/18/2004 | CN1475249A Fatty acid synthetic enzyme inhibitor and its production method and application |
| 02/18/2004 | CN1475234A Medicinal composition for treating cancer |
| 02/18/2004 | CN1475233A Preparation method of powdered Chinese medicine for treating esophagus cancer |
| 02/18/2004 | CN1475232A Chinese medicine composition capsule for treating lung cancer and its preparation method |
| 02/18/2004 | CN1475227A Composition for preventing and treating climacteric sgndrome, osteoporosis and mastocancer |
| 02/18/2004 | CN1475218A Medicinal preparation composed of diphosphate and aminoglucose salt and its use |
| 02/18/2004 | CN1475210A New use of agmatine |
| 02/18/2004 | CN1138787C Natural plant polyose |
| 02/18/2004 | CN1138784C Action of antisense nucleic acid pointing at urokinase type plasminogen activating agent gene for inhibiting cancer |
| 02/18/2004 | CN1138778C Bicyclic pyrimidines and bicyclic 3,4-dihydropyrimidines as inhibitors of cellular proliferation |
| 02/18/2004 | CN1138774C Substituted 6,6-hetero-bicyclic derivatives |
| 02/18/2004 | CN1138773C 4-alkenyl (and alkynyl) oxindoles as inhibitors of cell cycle protein dependent kinases, in particular CDK2 |
| 02/18/2004 | CN1138771C 6-hydroxy-3-(4-[2-piperidine-1-group) oxyethyl group] phenoxy)-2-(4-methoxyphenyl) benzo[b] thiophene hydrochloride salt |
| 02/18/2004 | CN1138770C 6-carbonyl-3-(4-[2-pierid-1-yl)elhoyl]phenoxy)-2-(4-methoxylphenyl) benzo[b] thiophene salt crystal |
| 02/18/2004 | CN1138760C Preparation and use of ortho-sulfonamido bicyclic heteroaryl hydroxamic acids as matrix metalloproteinase and TACE inhibitors |